Clopidogrel
Key facts
Invented name |
Clopidogrel BMS
|
Active substance |
clopidogrel
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/190/2009
|
PIP number |
Clopidogrel
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Thromboembolic events
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Bristol-Myers Squibb Pharma EEIG
E-mail: sylvie.gabriel@sanofi-aventis.com |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|